In 2019 iMedX will be completing the final phase of the OzeScribe acquisition in Australia by phasing out the OzeScribe brand. This is to better align the branding across multiple Clinical Information solutions which we offer in Australia, New Zealand and the United States – not just transcription!
OzeScribe is iMedX in Australia
Our website and emails are changing, but our people, service, and quality are not!
FREQUENTLY ASKED QUESTIONS
When will this occur?
iMedX will be redirecting from the ozescribe.com.au domain by the end of Q1 in 2019. We will begin communicating in early 2019.
What will happen if send an email to an @ozescribe address?
Your emails will still be answered as all contact points will forward to their respective imedx.com.au address. You will receive a response from an @imedx.com.au domain.
What else is changing?
Nothing! The locally managed Australian operations team based in Melbourne will remain unchanged and continue to manage your service across all sales, account management, invoicing and support roles! Similarly our phone, and fax numbers will remain unchanged.